Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

 plays        
How to Play
HintAnswer
First line drugs for disease modification
Axathioprine class
Dose: 1250 mg/day PO for 3-5 days
Prednisone class
Fingolimod class
Natalizumab class
Methylprednisone class
Carbamazepine class
MOA: alkylating agent
Use: pain and paroxysmal disorders
Modafinil class
Baclofen class
IFN beta 1-a (Avonex) class
Methylphenidate class
Venlafaxine class
Dose: Oral daily (first PO MS drug)
Use: Depression. Also helps with fatigue
Dose: 1 gram/day IV for 3-5 days
Dalfampridine class
Dose: SC injection 2-3 times weekly
Tizanidine class
Second line agent for RRMS that produces reduction in progression of disabilty
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
HintAnswer
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Use: For pts who do not respond to corticosteroids during acute attacks
Second line agent MOA: monoclonal Ab
Gabapentin class
Use: Depression. Also helps with pain
IFN beta 1-a (Rebif) class
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: IM weekly
Tricyclic class
Alemtizumab class
First line RRMS agent injected SC daily
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Mitoxantrone class
Dose: Oral. In extreme cases intrathecal
Use: treatment of spasticity
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Daclizumab class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Cyclophosphamide class
Second line agent: RRMS. Reduced relapses & progression of disability
Glatiramer acetate class
HintAnswer
Use: Fatigue, cognitive impairment (long acting agent)
Excreted by kidney: contraindicated in moderate to severe renal failure
MOA: Immune modulator, exact mechanism not known.
MOA: Immunomodulator/antineoplastic
Bupropion class
Use: Fatigue
MOA: Antimetabolite and antifolate
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Rituximab class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
MOA: Purine analog
Second line agent given IV monthy
Off line agent used in the treatment of acute attacks
Dose: SC injection every other day
IFN beta 1-b (Betaseron) class
Duloxetine class
MOA: Anti-organ rejection drug
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Mycophenolate class
Dose: IV infusion every 3 months
Plasmapheresis class
Methotrexate class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 18, 2011ReportNominate
Tags:agent, multiple